Loading…

Parathyroid Disorders of Pregnancy

Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in perinatology 1998-12, Vol.22 (6), p.485-496
Main Author: Mestman, Jorge H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323
cites cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323
container_end_page 496
container_issue 6
container_start_page 485
container_title Seminars in perinatology
container_volume 22
creator Mestman, Jorge H.
description Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.
doi_str_mv 10.1016/S0146-0005(98)80028-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69121926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0146000598800281</els_id><sourcerecordid>69121926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</originalsourceid><addsrcrecordid>eNqFkM1LAzEQxYMotVb_hELxIHpYndkku8lJpH5CwYIK3kI2Hxppd2uyFfrfu7WlV08D896b4f0IGSJcImBx9QLIigwA-LkUFwIgFxnukT5yLjIo-fs-6e8sh-QopS8AyiRCj_SkEIAo-uR0qqNuP1exCXZ0G1ITrYtp1PjRNLqPWtdmdUwOvJ4ld7KdA_J2f_c6fswmzw9P45tJZmgBbeZ1XpXGWQPUMa5txbxlnDGwYI3mFcoSCtSMo_dyvaG8lOhpaRgtJM3pgJxt7i5i8710qVXzkIybzXTtmmVShcQcZV50Rr4xmtikFJ1XixjmOq4UglqzUX9s1Lq4kkL9sVHY5YbbB8tq7uwutYXR6dcb3XUtf4KLKpng6q5TiM60yjbhnw-_3QJyPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69121926</pqid></control><display><type>article</type><title>Parathyroid Disorders of Pregnancy</title><source>ScienceDirect Freedom Collection</source><creator>Mestman, Jorge H.</creator><creatorcontrib>Mestman, Jorge H.</creatorcontrib><description>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</description><identifier>ISSN: 0146-0005</identifier><identifier>EISSN: 1558-075X</identifier><identifier>DOI: 10.1016/S0146-0005(98)80028-1</identifier><identifier>PMID: 9880118</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Female ; Humans ; Hypercalcemia - etiology ; Hyperparathyroidism - complications ; Hyperparathyroidism - therapy ; Hypoparathyroidism ; Osteoporosis ; Parathyroid Diseases ; Pregnancy ; Pregnancy Complications ; Pseudohypoparathyroidism</subject><ispartof>Seminars in perinatology, 1998-12, Vol.22 (6), p.485-496</ispartof><rights>1998 W.B. Saunders Company. All rights reserved</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</citedby><cites>FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9880118$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mestman, Jorge H.</creatorcontrib><title>Parathyroid Disorders of Pregnancy</title><title>Seminars in perinatology</title><addtitle>Semin Perinatol</addtitle><description>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</description><subject>Female</subject><subject>Humans</subject><subject>Hypercalcemia - etiology</subject><subject>Hyperparathyroidism - complications</subject><subject>Hyperparathyroidism - therapy</subject><subject>Hypoparathyroidism</subject><subject>Osteoporosis</subject><subject>Parathyroid Diseases</subject><subject>Pregnancy</subject><subject>Pregnancy Complications</subject><subject>Pseudohypoparathyroidism</subject><issn>0146-0005</issn><issn>1558-075X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkM1LAzEQxYMotVb_hELxIHpYndkku8lJpH5CwYIK3kI2Hxppd2uyFfrfu7WlV08D896b4f0IGSJcImBx9QLIigwA-LkUFwIgFxnukT5yLjIo-fs-6e8sh-QopS8AyiRCj_SkEIAo-uR0qqNuP1exCXZ0G1ITrYtp1PjRNLqPWtdmdUwOvJ4ld7KdA_J2f_c6fswmzw9P45tJZmgBbeZ1XpXGWQPUMa5txbxlnDGwYI3mFcoSCtSMo_dyvaG8lOhpaRgtJM3pgJxt7i5i8710qVXzkIybzXTtmmVShcQcZV50Rr4xmtikFJ1XixjmOq4UglqzUX9s1Lq4kkL9sVHY5YbbB8tq7uwutYXR6dcb3XUtf4KLKpng6q5TiM60yjbhnw-_3QJyPw</recordid><startdate>19981201</startdate><enddate>19981201</enddate><creator>Mestman, Jorge H.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19981201</creationdate><title>Parathyroid Disorders of Pregnancy</title><author>Mestman, Jorge H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Female</topic><topic>Humans</topic><topic>Hypercalcemia - etiology</topic><topic>Hyperparathyroidism - complications</topic><topic>Hyperparathyroidism - therapy</topic><topic>Hypoparathyroidism</topic><topic>Osteoporosis</topic><topic>Parathyroid Diseases</topic><topic>Pregnancy</topic><topic>Pregnancy Complications</topic><topic>Pseudohypoparathyroidism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mestman, Jorge H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in perinatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mestman, Jorge H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parathyroid Disorders of Pregnancy</atitle><jtitle>Seminars in perinatology</jtitle><addtitle>Semin Perinatol</addtitle><date>1998-12-01</date><risdate>1998</risdate><volume>22</volume><issue>6</issue><spage>485</spage><epage>496</epage><pages>485-496</pages><issn>0146-0005</issn><eissn>1558-075X</eissn><abstract>Diseases of the parathyroid gland are uncommon in women of childbearing age. However, total serum calcium is lower in normal pregnancy, but ionized serum calcium remains within normal limits. Serum parathyroid levels are slightly decreased in the second half of pregnancy. Primary hyperparathyroidism, if unrecognized, may increase maternal and fetal morbidity, which is related to the level of serum calcium. The most common cause is a single parathyroid adenoma, accounting for about 80% of cases. Maternal complications include acute pancreatitis, hypercalcemia crisis, and toxemia. An increased incidence of prematurity and neonatal hypocalcemia has been reported when maternal hypercalcemia is significantly elevated. Other causes of hypercalcemia are rare in pregnancy. Hypoparathyroidism is seldom seen in pregnancy; the most common cause is after surgical throidectomy. The doses of vitamin D and calcium do not change during pregnancy; however, hypercalcemia may develop in the postpartum period. Serum calcium should be determined at every trimester of pregnancy and at regular intervals after delivery, and in a significant number of patients, the dose of vitamin D should be reduced. Osteoporosis has been recognized most frequently in the last few years. It appears that those patients with a family history of osteoporosis and those on heparin therapy have a tendency to develop symptoms of the disease in pregnancy. Finally, lactation is not contraindicated in women with osteoporosis; although there is a slight decrease in bone density in the few months after delivery, this is a transient event and bone densitometry returns to prepregnancy levels in most women. Recent studies indicate that there is no need for calcium therapy during lactation with few exceptions, such as lactating adolescents, mothers nursing more than one child, and mothers with closely-spaced pregnancies.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>9880118</pmid><doi>10.1016/S0146-0005(98)80028-1</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0146-0005
ispartof Seminars in perinatology, 1998-12, Vol.22 (6), p.485-496
issn 0146-0005
1558-075X
language eng
recordid cdi_proquest_miscellaneous_69121926
source ScienceDirect Freedom Collection
subjects Female
Humans
Hypercalcemia - etiology
Hyperparathyroidism - complications
Hyperparathyroidism - therapy
Hypoparathyroidism
Osteoporosis
Parathyroid Diseases
Pregnancy
Pregnancy Complications
Pseudohypoparathyroidism
title Parathyroid Disorders of Pregnancy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A41%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parathyroid%20Disorders%20of%20Pregnancy&rft.jtitle=Seminars%20in%20perinatology&rft.au=Mestman,%20Jorge%20H.&rft.date=1998-12-01&rft.volume=22&rft.issue=6&rft.spage=485&rft.epage=496&rft.pages=485-496&rft.issn=0146-0005&rft.eissn=1558-075X&rft_id=info:doi/10.1016/S0146-0005(98)80028-1&rft_dat=%3Cproquest_cross%3E69121926%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c360t-fa2b7cedc03e45adb4fd45440d0dca5b197061a451ff9dca535791f37c4369323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69121926&rft_id=info:pmid/9880118&rfr_iscdi=true